Skip to content
  • info@BioLifeSolutions.com
  • 1.866.424.6543
  • Toggle search form
  • Toggle shopping cart 0

    Cart

  • Products
    • CryoStor®
      • CryoStor CS10
      • CryoStor CS5
      • CryoStor CS2
    • HypoThermosol®
      • HypoThermosol®
      • HypoThermosol for Hair
    • BloodStor®
      • BloodStor 100
      • BloodStor 55-5
      • BloodStor 27
    • Cell Thawing Media®
      • 10% Dextran 40 (IN 0.9% NaCl)
      • 10% Dextran 40 (IN 5% Dextrose)
    • All Products
  • Resources
    • Certificate of Analysis
    • Blog
    • Events
    • BioPreservation Today
    • White Papers
    • Press Releases
  • Evidence
    • Resource Links
  • Company
    • About
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Quality Management System
    • Distributors
    • Current Job Openings
  • Investors
    • Investors Home
    • Governance
    • Press Releases
    • Financials
    • Stock Information
    • Management Team
    • Investor Contact
  • Contact
    • General Inquiries
    • Master File Request
    • SDS Request Form
    • Sample Request
  • Ask the Scientists
  • ORDER
Close navigation
  • Primary Menu
BioLife Solutions

BioLife Solutions

Biopreservation Tools For Cells, Tissues, and Organs

Close search

Search

Search for:
Home/Blog/Tag: “HypoThermosol”

Tag: HypoThermosol

Cell therapies for trauma and critical care medicine: critical issues in translation for cellular and novel therapies in trauma and critical care

Stroncek, D., Mathew, A., & McKenna, D. Cell therapies for trauma and critical care medicine: critical issues in translation for cellular and novel therapies in trauma and critical care. Transfusion. 2019; 59(S1), 854-857. doi:10.1111/trf.14832

Read More

Cell therapies for trauma and critical care medicine: critical issues in translation for cellular and novel therapies in trauma and critical care

Stroncek, D., Mathew, A., & McKenna, D. Cell therapies for trauma and critical care medicine: critical issues in translation for cellular and novel therapies in trauma and critical care. Transfusion. 2019; 59(S1), 854-857. doi:10.1111/trf.14832

Read More

Development and validation of broad-spectrum magnetic particle labelling processes for cell therapy manufacturing

Harrison, R., Lugo Leija, H. A., Strohbuecker, S., Crutchley, J., Marsh, S., Denning, C., El Haj, A., Sottile, V.  Development and validation of broad-spectrum magnetic particle labelling processes for cell therapy manufacturing.   Stem Cell Res Ther, 2018 Sept 26; 9(1):248.  doi:10.1186/s13287-018-0968-0.

Read More

Mesenchymal Stromal Cells Based Therapy in Systemic Sclerosis: Rational and Challenges

Peltzer, J., Aletti, M., Frescaline, N., Busson, E., Lataillade, J. and Martinaud, C. Mesenchymal Stromal Cells Based Therapy in Systemic Sclerosis: Rational and Challenges. Front. Immunol. September 2018; 9:2013. doi:10.3389/fimmu.2018.02013

Read More

Practical considerations for clinical use of mesenchymal stem cells: From the laboratory to the horse

Barrachina, L., Romero, A., Zaragoza, P., Rodellar, C., Vázquez, F.  Practical considerations for clinical use of mesenchymal stem cells: From the laboratory to the horse.  The Veterinary Journal. 2018; 238, 49-57.  doi:10.1016/j.tvjl.2018.07.004

Read More

Practical considerations for clinical use of mesenchymal stem cells: From the laboratory to the horse

Barrachina, L., Romero, A., Zaragoza, P., Rodellar, C., Vázquez, F.   Practical considerations for clinical use of mesenchymal stem cells: From the laboratory to the horse.  The Veterinary Journal. 2018; 238, 49-57.  doi:10.1016/j.tvjl.2018.07.004

Read More

The Importance of Collection, Processing and Biopreservation Best Practices in Determining CAR-T Starting Material Quality

Lou Juliano, George Eastwood, Todd Berard, Aby J. Mathew. The Importance of Collection, Processing and Biopreservation Best Practices in Determining CAR-T Starting Material Quality. Cell Gene Therapy Insights 2018; 4(4), 327-336. doi: 10.18609/cgti.2018.032

Read More

The Importance of Collection, Processing and Biopreservation Best Practices in Determining CAR-T Starting Material Quality

Lou Juliano, George Eastwood, Todd Berard, Aby J. Mathew. The Importance of Collection, Processing and Biopreservation Best Practices in Determining CAR-T Starting Material Quality. Cell Gene Therapy Insights 2018; 4(4), 327-336. doi: 10.18609/cgti.2018.032

Read More

Discogenic cell transplantation directly from a cryopreserved state in an induced intervertebral disc degeneration canine model

Hiraishi, S., Schol, J., Sakai, D., Nukaga, T., Erickson, I., Silverman, L., Foley, K., Watanabe, M. Discogenic cell transplantation directly from a cryopreserved state in an induced intervertebral disc degeneration canine model. JOR Spine. (2018); 1(2), e1013. doi:10.1002/jsp2.1013

Read More

Discogenic cell transplantation directly from a cryopreserved state in an induced intervertebral disc degeneration canine model

Hiraishi, S., Schol, J., Sakai, D., Nukaga, T., Erickson, I., Silverman, L., Foley, K., Watanabe, M. Discogenic cell transplantation directly from a cryopreserved state in an induced intervertebral disc degeneration canine model. JOR Spine. (2018); 1(2), e1013. doi:10.1002/jsp2.1013

Read More

Navigation

1 2 … 13 Next Page
Search for:

Blog Archives

Signup Area

Sign Up for Email Updates

Biolife Logo

  • Products
  • Company
  • Evidence
  • Investors
  • Blog
  • Ask the Scientists
  • Press Releases
  • Contact
© 2018 BioLifeSolutions Inc.  All Rights Reserved    |    Terms & Conditions    |    Privacy
  • twitter
  • linkedin
  • facebook